Clinical Trials Update: May 10, 2006
Depression Coronary Artery Disease Multiple Sclerosis
(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:
If you are experiencing symptoms of depression, you might be interested in a medical research study for adults, ages 21-64, who experience depression and trouble falling asleep or staying asleep.
If you qualify, all study-related care will be provided at no cost, and you will be compensated up to $275 for time and travel.
The research site is in Jacksonville, Fla.
Coronary Artery Disease
People with coronary artery disease (CAD) are needed for a research study conducted at St. Vincent's Catholic Medical Centers in New York City.
Eligible participants must be a male or a post-menopausal female between the ages of 55 and 80 and have a confirmed diagnosis of coronary artery disease.
The research site is in New York City.
The purpose of this study is to determine if the combined use of interferon beta 1-a weekly and glatiramer acetate daily as initial treatment for patients with relapsing remitting multiple sclerosis will help reduce relapse rate when compared to either agent alone.
Eligible patients will be required to visit their local clinic every three months over a three-year period -- 15 scheduled visits. All study-related visits and investigational drug therapies are provided at no cost.
Research sites are located throughout the United States.
Copyright 2006 CenterWatch. All rights reserved.